Abstract is: Jean-Claude Chermann is a French virologist who managed the research team which, by 1983, under the administrative supervision of Luc Montagnier, had discovered the virus associated with AIDS. Whereas second author of this initial publication and obviously involved as team manager in this discovery, he had been omitted from the Nobel Prize attributed to its colleagues. In 2008, as chairman of the support committee for the attribution of the Nobel Prize in medicine to Jean-Claude Chermann, Bernard Le Grelle, a political consultant, campaigned for the official recognition of this oversight with the Nobel committee by bringing together more than 700 doctors, professors and scientists (including professor Robert Gallo).The virus was named lymphadenopathy-associated virus, or LAV. A year later, a team led by Robert Gallo of the United States confirmed the discovery of the virus, but renamed it human T-lymphotropic virus type III (HTLV-III).
human | Q5 |
P2381 | Academic Tree ID | 92332 |
P3630 | Babelio author ID | 146340 |
P268 | Bibliothèque nationale de France ID | 118965560 |
P8179 | Canadiana Name Authority ID | ncf11178627 |
P11496 | CiNii Research ID | 1140000791583316608 |
P9371 | FranceArchives agent ID | 18899134 |
P646 | Freebase ID | /m/04z_csg |
P227 | GND ID | 139869786 |
P269 | IdRef ID | 026785196 |
P213 | ISNI | 0000000107793320 |
P244 | Library of Congress authority ID | n87122467 |
P271 | NACSIS-CAT author ID | DA05361800 |
P949 | National Library of Israel ID (old) | 005133279 |
P8189 | National Library of Israel J9U ID | 987007396499505171 |
P1006 | Nationale Thesaurus voor Auteursnamen ID | 130626503 |
P349 | NDL Authority ID | 00464491 |
P10632 | OpenSanctions ID | Q513246 |
P1005 | Portuguese National Library author ID | 200972 |
P3065 | RERO ID (obsolete) | 02-A003100449 |
P1045 | Sycomore ID | 10468 |
P214 | VIAF ID | 31994512 |
P4124 | Who's Who in France biography ID | 22364 |
P10832 | WorldCat Entities ID | E39PBJxd43dM4CK7QY8rcb6VG3 |
P166 | award received | King Faisal International Prize in Medicine | Q30868915 |
Officer of the Legion of Honour | Q10855195 | ||
Knight of the National Order of Merit | Q13422138 | ||
Great Gold medal of the Société d'Encouragement au Progrès | Q24954950 | ||
P27 | country of citizenship | France | Q142 |
P185 | doctoral student | Bruno Spire | Q18744660 |
P69 | educated at | Lycée Condorcet | Q926749 |
Lycée Michelet, Vanves | Q3268847 | ||
P734 | family name | Chermann | Q118558403 |
Chermann | Q118558403 | ||
Chermann | Q118558403 | ||
P101 | field of work | HIV/AIDS | Q12199 |
P735 | given name | Jean-Claude | Q3164791 |
Jean-Claude | Q3164791 | ||
P1412 | languages spoken, written or signed | French | Q150 |
P1559 | name in native language | Jean-Claude Chermann | |
P106 | occupation | physician | Q39631 |
politician | Q82955 | ||
virologist | Q15634281 | ||
P1327 | partner in business or sport | Françoise Barré-Sinoussi | Q103844 |
Willy Rozenbaum | Q2945169 | ||
Françoise Brun-Vézinet | Q3086421 | ||
Marie-Thérèse Nugeyre | Q59592199 | ||
Françoise Rey | Q86877835 | ||
Claudine Axler-Blin | Q117278389 | ||
Sophie Chamaret | Q118557247 | ||
Jacqueline Gruest | Q118557762 | ||
Charles Dauguet | Q118558049 | ||
Luc Montagnier | Q103598 | ||
Christine Rouzioux | Q28595176 | ||
P39 | position held | member of the French National Assembly | Q3044918 |
P21 | sex or gender | male | Q6581097 |
P937 | work location | Paris | Q90 |
Q72915570 | 2-L-Rhamnopyranosyl[1,2,4]triazolo[1,5-a]pyridine. 4' and 3' Oxidation products. Synthesis and structure-activity relationships |
Q70123163 | A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells |
Q70098592 | A new human retrovirus associated with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex |
Q45796470 | Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines |
Q55245352 | Antibodies to HTLV I and III in sera from two Japanese patients, one with possible pre-AIDS. |
Q45796312 | Antibodies to the Core Protein of Lymphadenopathy-Associated Virus (LAV) in Patients with AIDS |
Q69857527 | Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome |
Q71669354 | Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications |
Q71154896 | Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia |
Q69044539 | Cellular and molecular mechanisms of antiretroviral effects of HPA23 |
Q69074896 | Characterization of a reverse transcriptase activity associated with retrovirus-like particles in a Drosophila cell line |
Q45804377 | Characterization of the RNA dependent DNA polymerase of a new human T lymphotropic retrovirus (lymphadenopathy associated virus) |
Q68998826 | Characterization of the purified RNA dependent DNA polymerase isolated from Drosophila |
Q72717024 | Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases |
Q68242489 | Cultured trophoblastic choriocarcinoma cells differentially express HIV-1 and cloned provirus |
Q66901995 | Cytotoxic and antitumor activity of a new series of heterocyclic compounds: dipyrido (4,3-b) (3,4-f) indoles |
Q44394636 | Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells |
Q45806118 | Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome |
Q41725738 | Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR). |
Q47353668 | Differential inhibition of the activities of reverse transcriptase and various cellular DNA polymerases by a traditional Kampo drug, Sho-saiko-to |
Q54376667 | Differential inhibition of various mammalian DNA polymerase activities by ammonium 21-tungsto-9-antimoniate (HPA23). |
Q28323433 | Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases |
Q45852804 | Discrepancies in AIDS virus data |
Q39437630 | Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages |
Q39586699 | Enhancement of retrovirus production by anti-interferon serum |
Q56831451 | Epidemiology of HIV1 infection among randomized representative Central African populations |
Q55243410 | Genetic comparison of LAV-related isolates. |
Q39068750 | Genetic control of infection of primary macrophages with T-cell-tropic strains of HIV-1. |
Q55244360 | Genomic variability of selected LAV-related AIDS retroviruses. |
Q41634041 | HIV-1 infectivity of human carcinoma cell lines lacking CD4 receptors |
Q44611539 | HIV-I and HIV-II double infection in Central African Republic |
Q41640725 | HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect |
Q45806106 | High prevalence of lymphadenopathy virus (LAV) in European haemophiliacs |
Q41667546 | Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity |
Q44003611 | Human immunodeficiency virus inhibition by lysed leukocyte ultrafiltrate |
Q36684585 | Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. |
Q44060107 | Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus |
Q45796183 | Immune status of AIDS patients in France: relationship with lymphadenopathy associated virus tropism. |
Q43972446 | Immunohistochemical reactivity of anti-LAV p18 monoclonal antibody in lymph nodes from PGL and AIDS patients |
Q70977713 | In vivo Effect of a New Mineral Condensed Ion (HPA 39) on Murine Friend Leukaemia |
Q43786915 | Inactivation of lymphadenopathy associated virus by chemical disinfectants |
Q45840287 | Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light |
Q70387016 | Induction of cellular DNA polymerases in a Burkitt lymphoma-derived cell line by treatment with 5-iododeoxyuridine |
Q67896083 | Infection of HIV-1 and HIV-2 through the luminal and serosal sides of polarized human intestinal epithelial cells |
Q72409570 | Inhibition of DNA polymerase alpha activity by ammonium 21-tungsto-9-antimoniate (HPA23) |
Q43859493 | Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate |
Q28339888 | Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone |
Q45833182 | Interrelations of lymphocyte subset values, human immunodeficiency virus antibodies, and HIV antigen levels of homosexual males in San Francisco |
Q34250390 | Isolation of a New Retrovirus in a Patient at Risk for Acquired Immunodeficiency Syndrome |
Q22242256 | Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) |
Q48649694 | Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. |
Q45838983 | Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. |
Q44866062 | Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS |
Q52849599 | Laboratory and serological studies argue against possible transmission of AIDS by hepatitis B vaccine. |
Q44437875 | Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual men. |
Q45796469 | Lymphadenopathy Associated Virus Infection of a Blood Donor—Recipient Pair with Acquired Immunodeficiency Syndrome |
Q45838185 | Lymphadenopathy associated virus (L.A.V.): its association with AIDS or prodromes |
Q72416448 | Lymphadenopathy associated virus and its etiological role in AIDS |
Q45806090 | Lymphadenopathy associated virus in AIDS, lymphadenopathy associated syndrome, and classic Kaposi patients in Greece |
Q41529519 | Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state |
Q45838589 | Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis |
Q45796807 | Modulation by the Polyoxotungstate HPA-23 of Epstein--Barr Virus Early Antigen Expression in Raji Cells Treated with Iododeoxyuridine |
Q34707015 | Molecular cloning of lymphadenopathy-associated virus |
Q36244894 | Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus |
Q72742259 | Organ distribution of reverse transcriptase and cellular DNA polymerases in Friend virus-infected mice: analysis by phosphocellulose column chromatography |
Q70356509 | Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2 |
Q55062347 | Possible transmission of a human lymphotropic retrovirus (LAV) from mother to infant with AIDS. |
Q54134707 | Prevalence of Antibodies to Lymphadenopathy-Associated Retrovirus in African Patients with AIDS |
Q43460845 | Prevalence of antibodies to lymphadenopathy-AIDS virus in French haemophiliacs |
Q41694235 | Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies |
Q69050282 | RNA-dependent DNA polymerase activity is regulated by ecdysterone in a Drosophila cell line |
Q40378772 | Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells |
Q45840220 | Resistance of AIDS virus at room temperature |
Q72392730 | Retroviruses and acquired immunodeficiency syndrome (AIDS) |
Q39672454 | Role of the human immunodeficiency virus in the physiopathology of AIDS. |
Q44544283 | Screening for lymphadenopathy/AIDS virus in bone marrow-transplant recipients. |
Q45859080 | Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells |
Q39140204 | Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes |
Q43504451 | Sequence analysis of original HIV-1. |
Q45797064 | Sequences related to mouse mammary tumor virus genome in tumor cells and lymphocytes from patients with breast cancer |
Q41680490 | Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. |
Q40060923 | The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain |
Q70094158 | The possible role of a new lymphotropic retrovirus (LAV) in the pathogeny of AIDS and AIDS-related diseases |
Q45838178 | Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome |
Q45836487 | Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases |
Q55244258 | Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families. |
Q67014052 | Zonal centrifuge purification of human rabies vaccine obtained on bovine foetal kidney cells (author's transl) |
Q52458640 | [Infection of insect cell lines by the HIV virus, an agent of AIDS, and a demonstration of insects of African origin infected by this virus]. |
Q70098816 | [Prevalence of anti-LAV antibodies in hemophiliacs, correlation with the immunological state] |
Q118558049 | Charles Dauguet |
Q28595176 | Christine Rouzioux |
Q117278389 | Claudine Axler-Blin |
Q103844 | Françoise Barré-Sinoussi |
Q3086421 | Françoise Brun-Vézinet |
Q86877835 | Françoise Rey |
Q118557762 | Jacqueline Gruest |
Q103598 | Luc Montagnier |
Q59592199 | Marie-Thérèse Nugeyre |
Q118557247 | Sophie Chamaret |
Q2945169 | Willy Rozenbaum |
Q18744660 | Bruno Spire | doctoral advisor | P184 |
Q39055018 | HPA-23 | discoverer or inventor | P61 |
Arabic (ar / Q13955) | جان- كلود شيرمان | wikipedia |
Egyptian Arabic (arz / Q29919) | جان كلود شيرمان | wikipedia |
Jean-Claude Chermann | wikipedia | |
Jean-Claude Chermann | wikipedia | |
Jean-Claude Chermann | wikipedia | |
Jean-Claude Chermann | wikipedia |
Search more.